Article open access publication

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

JAMA, American Medical Association (AMA), ISSN 0098-7484

Volume 317, 23, 2017

DOI:10.1001/jama.2017.7112, Dimensions: pub.1086082777, PMID: 28632866,

Affiliations

Organisations

  1. (1) Wellcome Sanger Institute, grid.10306.34
  2. (2) University of Cambridge, grid.5335.0
  3. (3) University of Melbourne, grid.1008.9
  4. (4) Department of Medicine, St Vincent’s Hospital, University of Melbourne, Parkville, Australia
  5. (5) Peter MacCallum Cancer Centre, grid.1055.1
  6. (6) Antoni van Leeuwenhoek Hospital, grid.430814.a
  7. (7) Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
  8. (8) University of Warwick, grid.7372.1
  9. (9) Cancer Council Victoria, grid.3263.4
  10. (10) Mines ParisTech, grid.58140.38
  11. (11) PSL Research University, grid.440907.e
  12. (12) Institute Curie, grid.418596.7
  13. (13) University of Utah, grid.223827.e
  14. (14) Columbia University, grid.21729.3f
  15. (15) University of Manchester, grid.5379.8
  16. (16) Chapel Allerton Hospital, grid.413818.7
  17. (17) West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Birmingham, England
  18. (18) Guy's and St Thomas' NHS Foundation Trust, grid.420545.2
  19. (19) Royal Marsden NHS Foundation Trust, grid.5072.0
  20. (20) University of Glasgow, grid.8756.c
  21. (21) University College London, grid.83440.3b
  22. (22) Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France
  23. (23) Centre Léon Bérard, grid.418116.b
  24. (24) Paris Descartes University, grid.10992.33
  25. (25) UniCancer Group, grid.418189.d
  26. (26) Centre Hospitalier Regional Universitaire De Dijon, grid.31151.37
  27. (27) Centre de Lutte Contre le Cancer Georges François Leclerc, Dijon, France
  28. (28) Erasmus University Medical Center, grid.5645.2
  29. (29) Radboud University Nijmegen Medical Centre, grid.10417.33
  30. (30) VU University Medical Center, grid.16872.3a
  31. (31) Cancer Prevention Institute of California, grid.280669.3
  32. (32) Lunenfeld-Tanenbaum Research Institute, grid.250674.2
  33. (33) University of Toronto, grid.17063.33
  34. (34) Temple University Health System, grid.412530.1
  35. (35) Huntsman Cancer Institute, grid.479969.c
  36. (36) Centre for Biomedical Network Research on Rare Diseases, grid.452372.5
  37. (37) Spanish National Cancer Research Centre, grid.7719.8
  38. (38) Leipzig University, grid.9647.c
  39. (39) German Cancer Research Center, grid.7497.d
  40. (40) National Center for Tumor Diseases, grid.461742.2
  41. (41) University Hospital Carl Gustav Carus, grid.412282.f
  42. (42) University Hospital Cologne, grid.411097.a
  43. (43) Hospital Clínico San Carlos, grid.411068.a
  44. (44) Pomeranian Medical University, grid.107950.a
  45. (45) Laval University, grid.23856.3a
  46. (46) Prince of Wales Hospital, grid.415193.b
  47. (47) UNSW Sydney, grid.1005.4
  48. (48) St Vincent's Hospital, grid.413105.2
  49. (49) Masaryk Memorial Cancer Institute, grid.419466.8
  50. (50) QIMR Berghofer Medical Research Institute, grid.1049.c
  51. (51) Medical University of Vienna, grid.22937.3d
  52. (52) National Institute of Oncology, grid.419617.c
  53. (53) Department of Clinical Genetics, Copenhagen University Hospital Rigshospital, Copenhagen, Denmark
  54. (54) Karolinska Institute, grid.4714.6
  55. (55) Skåne University Hospital, grid.411843.b

Funders

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Copenhagen

Danish Open Access Indicator

2017: Blocked

Research area: Medicine

Danish Bibliometrics Indicator

2017: Level 2

Research area: Medicine

Dimensions Citation Indicators

Times Cited: 590

Field Citation Ratio (FCR): 211.21

Relative Citation ratio (RCR): 40.96

Open Access Info

Bronze